HuGE Literature Finder
|
||
Records 1-11
|
Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome.
Carcinogenesis 2015 Sep 36 (9): 956-62. Eng Lawson, Azad Abul Kalam, Qiu Xin, Kong Qin Quinn, Cheng Dangxiao, Ying Nanjiao, Tse Alvina, Kuang Qin, Dodbiba Lorin, Renouf Daniel J, Marsh Sharon, Savas Sevtap, Mackay Helen J, Knox Jennifer J, Darling Gail E, Wong Rebecca K S, Xu Wei, Liu Geoffrey, Faluyi Olusola |
|
Role of +405C>G and +936C>T polymorphisms of the vascular endothelial growth factor gene and risk of esophageal cancer in the Kashmiri population.
Asian Pacific journal of cancer prevention : APJCP 2015 16 (1): 97-101. Qasim Iqbal, Bhat Imtiyaz Ahmad, Masoodi Khalid Zafar, Shah Zafar Am |
|
Variant alleles of VEGF and risk of esophageal cancer and lymph node metastasis.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2014 May 19 (3): 252-8. Gu Haiyong, Qiu Wanshan, Shi Yijun, Chen Suocheng, Yin J |
|
Genetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cell carcinoma.
PloS one 2014 9 (6): e100326. Yang Pei-Wen, Hsieh Min-Shu, Huang Ya-Chuan, Hsieh Ching-Yueh, Chiang Tzu-Hsuan, Lee Jang-Mi |
|
VEGF -634C/G Genotype is Predictive of Long-term Survival after Treatment with a Definitive 5-Fluorouracil/cisplatin-based Chemoradiotherapy in Japanese Patients with Esophageal Squamous Cell Carcinoma.
International journal of medical sciences 2012 9 (10): 10. Tamura T, Kuwahara A, Yamamori M, Nishiguchi K, Nakamura T, Okuno T, Miki I, Manabe Y, Sakaeda T |
|
Association of the VEGF 936C>T polymorphism with FDG uptake, clinical, histopathological, and metabolic response in patients with adenocarcinomas of the esophagogastric junction.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2011 Feb 13 (1): 178-86. Lorenzen Sylvie, Panzram Ben, Keller Gisela, Lordick Florian, Herrmann Ken, Becker Karin, Langer Ruppert, Schwaiger Markus, Siewert Jorg Rudiger, Ott Kat |
|
Cetuximab as second-line therapy in patients with metastatic esophageal adenocarcinoma: a phase II Southwest Oncology Group Study (S0415).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 Sep 5 (9): 1472-6. Gold Philip J, Goldman Bryan, Iqbal Syma, Leichman Lawrence P, Zhang Wu, Lenz Heinz-Josef, Blanke Charles |
|
A Large-scale genetic association study of esophageal adenocarcinoma risk.
Carcinogenesis 2010 Jul 31 (7): 1259-63. Liu Chen-Yu, Wu Michael C, Chen Feng, Ter-Minassian Monica, Asomaning Kofi, Zhai Rihong, Wang Zhaoxi, Su Li, Heist Rebecca S, Kulke Matthew H, Lin Xihong, Liu Geoffrey, Christiani David |
|
Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Jul 15 (14): 14. Bradbury PA, Zhai R, Ma C, Xu W, Hopkins J, Kulke MJ, Asomaning K, Wang Z, Su L, Heist RS, Lynch TJ, Wain JC, Christiani D, Liu G |
|
Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk.
Carcinogenesis 2008 Dec 29 (12): 2330-4. Zhai Rihong, Liu Geoffrey, Asomaning Kofi, Su Li, Kulke Matthew H, Heist Rebecca S, Nishioka Norman S, Lynch Thomas J, Wain John C, Lin Xihong, Christiani David |
|
VEGF G-1154A is predictive of severe acute toxicities during chemoradiotherapy for esophageal squamous cell carcinoma in Japanese patients.
Therapeutic drug monitoring 2008 Aug 30 (4): 497-503. Sakaeda Toshiyuki, Yamamori Motohiro, Kuwahara Akiko, Hiroe Satoko, Nakamura Tsutomu, Okumura Katsuhiko, Okuno Tatsuya, Miki Ikuya, Chayahara Naoko, Okamura Noboru, Tamura Tak |
- Page last reviewed:Mar 1, 2018
- Page last updated:Jun 13, 2019
- Content source: